Treatment of osteoporosis after alendronate or risedronate P. EikenP. Vestergaard Review 05 October 2015 Pages: 1 - 12
Does salmon calcitonin cause cancer? A review and meta-analysis G. WellsJ. ChernoffD. S. Krause Review Open access 05 October 2015 Pages: 13 - 19
Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study K. E. NaylorR. M. JacquesR. Eastell Original Article 20 May 2015 Pages: 21 - 31
Bone remodeling markers: so easy to measure, so difficult to interpret E. SeemanT. V. Nguyen Letter 11 November 2015 Pages: 33 - 35
Bone turnover markers: response to comments by Seeman and Nguyen K. E. NaylorR. M. JacquesR. Eastell Letter 11 November 2015 Pages: 37 - 37
Bone status in glucocorticoid-treated men and women E. S. LeibR. Winzenrieth Original Article 08 August 2015 Pages: 39 - 48
The utility of lumbar spine trabecular bone score and femoral neck bone mineral density for identifying asymptomatic vertebral fractures in well-compensated type 2 diabetic patients V. V. ZhukouskayaC. Ellen-VainicherI. Chiodini Original Article 03 July 2015 Pages: 49 - 56
Serotonergic antidepressant use and the risk of fracture: a population-based nested case–control study C.-Y. WangS.-H. FuF.-Y. Hsiao Original Article 01 July 2015 Pages: 57 - 63
Patients do not have a consistent understanding of high risk for future fracture: a qualitative study of patients from a post-fracture secondary prevention program J. E. M. SaleM. A. GignacV. Elliot-Gibson Original Article 27 June 2015 Pages: 65 - 73
Comorbidity indices for clinical trials: adaptation of two existing indices for use with the FREEDOM trial in women with postmenopausal osteoporosis S. L. SilvermanA. WangH. N. Viswanathan Original Article Open access 15 July 2015 Pages: 75 - 80
Zoledronic acid in children with osteogenesis imperfecta and Bruck syndrome: a 2-year prospective observational study G. A. OtaifyM. S. AglanS. A. Temtamy Original Article 03 July 2015 Pages: 81 - 92
Alkaline biodegradable implants for osteoporotic bone defects—importance of microenvironment pH W. LiuT. WangW. W. Lu Original Article 02 July 2015 Pages: 93 - 104
Serum 25-hydroxyvitamin D, parathyroid hormone, calcium intake, and bone mineral density in Spanish adults J. M. OlmosJ. L. HernándezJ. González-MacÃas Original Article 02 July 2015 Pages: 105 - 113
Relationship between subclinical thyroid dysfunction and the risk of fracture: a meta-analysis of prospective cohort studies Z. YanH. HuangJ. Wang Original Article 30 July 2015 Pages: 115 - 125
Trabecular bone score in type 1 diabetes—a cross-sectional study T. NeumannS. LodesA. Sämann Original Article 18 July 2015 Pages: 127 - 133
Evidence of a link between resting energy expenditure and bone remodelling, glucose homeostasis and adipokine variations in adolescent girls with anorexia nervosa L. MaïmounS. GuillaumeC. Sultan Original Article 06 August 2015 Pages: 135 - 146
Effect of IV contrast on lumbar trabecular attenuation at routine abdominal CT: correlation with DXA and implications for opportunistic osteoporosis screening P. J. PickhardtT. LauderN. Binkley Original Article 08 July 2015 Pages: 147 - 152
Abnormal subchondral bone microstructure following steroid administration is involved in the early pathogenesis of steroid-induced osteonecrosis L. WangL. ZhangW. W. Lu Original Article 09 July 2015 Pages: 153 - 159
Myostatin deficiency partially rescues the bone phenotype of osteogenesis imperfecta model mice A. K. OestreichS. M. CarletonC. L. Phillips Original Article 16 July 2015 Pages: 161 - 170
Low serum 25-hydroxyvitamin D is associated with increased risk of stress fracture during Royal Marine recruit training T. DaveyS. A. Lanham-NewJ. L. Fallowfield Original Article 10 July 2015 Pages: 171 - 179
Effect of whole-body vibration training on bone mass in adolescents with and without Down syndrome: a randomized controlled trial A. Matute-LlorenteA. González-AgüeroJ. A. Casajús Original Article 23 July 2015 Pages: 181 - 191
Cost-effectiveness of vitamin D supplementation and exercise in preventing injurious falls among older home-dwelling women: findings from an RCT R. PatilP. KoluK. Uusi-Rasi Original Article 24 July 2015 Pages: 193 - 201
Fracture prediction from repeat BMD measurements in clinical practice W. D. LeslieS. L. Brennan-OlsenL. M. Lix Original Article 05 August 2015 Pages: 203 - 210
Strontium ranelate as an adjuvant for fracture healing: clinical, radiological, and ultrasound findings in a randomized controlled study on wrist fractures M. ScaglioneL. FabbriG. Guido Original Article 21 August 2015 Pages: 211 - 218
Diabetes mellitus and risk of hip fractures: a meta-analysis Y. FanF. WeiY. Liu Original Article 12 August 2015 Pages: 219 - 228
Meta-analysis of diabetes mellitus and risk of hip fractures: small-study effect M. NazarzadehZ. BidelA. Sanjari Moghaddam Letter 26 October 2015 Pages: 229 - 230
Cost-effectiveness of a fracture liaison service—a real-world evaluation after 6 years of service provision J. H. E. YongL. MasucciD. Beaton Original Article 15 August 2015 Pages: 231 - 240
Evaluation of a simplified hip structure analysis method for the prediction of incident hip fracture events B. C. C. KhooJ. R. LewisR. L. Prince Original Article 18 August 2015 Pages: 241 - 248
Smoking, smoking cessation, and fracture risk in elderly women followed for 10 years M. H. ThorinA. WihlborgP. Gerdhem Original Article 25 August 2015 Pages: 249 - 255
Association between prolonged breastfeeding and bone mineral density and osteoporosis in postmenopausal women: KNHANES 2010-2011 I. R. HwangY. K. ChoiK. G. Park Original Article 15 September 2015 Pages: 257 - 265
FRAX predicts incident falls in elderly men: findings from MrOs Sweden N. C. HarveyH. JohanssonD. Mellström Original Article 21 September 2015 Pages: 267 - 274
Prevalence of sarcopenic obesity in Germany using established definitions W. KemmlerS. von StengelE. Freiberger Original Article 29 August 2015 Pages: 275 - 281
Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength W. YaoW. DaiN. E. Lane Original Article 18 September 2015 Pages: 283 - 294
The use of bisphosphonate in the treatment of osteonecrosis of the femoral head: a meta-analysis of randomized control trials H.-f. YuanC.-a. GuoZ.-q. Yan Original Article 14 September 2015 Pages: 295 - 299
Cost-effectiveness of personalized supplementation with vitamin D-rich dairy products in the prevention of osteoporotic fractures O. EthgenM. HiligsmannJ.-Y. Reginster Original Article Open access 22 September 2015 Pages: 301 - 308
Morning vs evening dosing of the cathepsin K inhibitor ONO-5334: effects on bone resorption in postmenopausal women in a randomized, phase 1 trial R. EastellD.-J. DijkS. Deacon Original Article Open access 07 October 2015 Pages: 309 - 318
Parity and osteoporotic fracture risk in postmenopausal women: a dose-response meta-analysis of prospective studies Q. WangQ. HuangJ.-a. Liu Original Article 06 October 2015 Pages: 319 - 330
Clinical utility of routine laboratory testing to identify possible secondary causes in older men with osteoporosis: the Osteoporotic Fractures in Men (MrOS) Study H. A. FinkS. Litwack-HarrisonFor the Osteoporotic Fractures in Men (MrOS) Study Group Original Article 12 October 2015 Pages: 331 - 338
Proton-pump inhibitors and risk of fractures: an update meta-analysis B. ZhouY. HuangJ. Liu Original Article 13 October 2015 Pages: 339 - 347
Calcium, proton pump inhibitors, and fracture risk T. SugiyamaT. TorioH. Oda Letter 10 November 2015 Pages: 349 - 350
Effects of switching weekly alendronate or risedronate to monthly minodronate in patients with rheumatoid arthritis: a 12-month prospective study K. EbinaT. NoguchiH. Yoshikawa Original Article 16 October 2015 Pages: 351 - 359
Hip fractures, preceding distal radius fractures and screening for osteoporosis: should we be screening earlier? A minimum 10-year retrospective cohort study at a single centre Z. J. DaruwallaS. S. HuqD. P. Murphy Original Article 28 October 2015 Pages: 361 - 366
Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation C. M. WeaverD. D. AlexanderD. D. Wang Original Article Open access 28 October 2015 Pages: 367 - 376
A phase 2 study of MK-5442, a calcium-sensing receptor antagonist, in postmenopausal women with osteoporosis after long-term use of oral bisphosphonates F. CosmanN. GilchristA. E. Denker Original Article 10 November 2015 Pages: 377 - 386
Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide study W. BrozekB. ReichardtE. Zwettler Original Article 17 November 2015 Pages: 387 - 396
Hyponatremia and hypernatremia are associated with increased 30-day mortality in hip fracture patients C. M. MadsenC. JantzenH. L. Jorgensen Original Article 17 November 2015 Pages: 397 - 404
Denosumab increases sublesional bone mass in osteoporotic individuals with recent spinal cord injury L. GifreJ. VidalP. Peris Short Communication 30 September 2015 Pages: 405 - 410
Towards better use of the net reclassification improvement (NRI) index W. D. LeslieJ. T. SchousboeL. M. Lix Letter 12 August 2015 Pages: 411 - 412
The real enemy is fragility fracture, not osteoporosis C. E. Uzoigwe Letter 13 November 2015 Pages: 413 - 415
A BMD threshold for treatment efficacy in osteoporosis? A need to consider the whole evidence base E. McCloskey Letter 13 November 2015 Pages: 417 - 419